Journey Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.9M Sell
21,679
-376
-2% -$381K 1.7% 15
2025
Q4
$23.7M Sell
22,055
-1,097
-5% -$1.05M 1.99% 9
2025
Q3
$17.7M Buy
23,152
+234
+1% +$174K 1.31% 17
2025
Q2
$17.9M Sell
22,918
-556
-2% -$432K 1.39% 14
2025
Q1
$19.4M Sell
23,474
-1,331
-5% -$1.11M 1.59% 11
2024
Q4
$22.5M Hold
24,805
2.69% 9
2024
Q3
$22.5M Sell
24,805
-12
-0% -$10.8K 2.69% 9
2024
Q2
$22.5M Sell
24,817
-4,623
-16% -$3.7M 2.69% 9
2024
Q1
$22.9M Buy
29,440
+622
+2% +$443K 2.82% 6
2023
Q4
$16.8M Sell
28,818
-290
-1% -$169K 2.28% 9
2023
Q3
$15.6M Sell
29,108
-499
-2% -$257K 2.34% 9
2023
Q2
$13.9M Sell
29,607
-719
-2% -$302K 2.07% 10
2023
Q1
$10.4M Buy
30,326
+1,461
+5% +$493K 1.63% 15
2022
Q4
$10.6M Buy
28,865
+3,900
+16% +$1.38M 2.63% 5
2022
Q3
$8.07M Buy
24,965
+2,251
+10% +$713K 2.06% 9
2022
Q2
$7.36M Buy
22,714
+4,497
+25% +$1.35M 1.69% 10
2022
Q1
$5.22M Buy
18,217
+1,866
+11% +$480K 1.32% 15
2021
Q4
$4.52M Buy
16,351
+499
+3% +$126K 1.25% 17
2021
Q3
$3.66M Sell
15,852
-380
-2% -$93.8K 1.19% 19
2021
Q2
$3.73M Buy
16,232
+405
+3% +$81.4K 1.18% 18
2021
Q1
$2.96M Buy
15,827
+409
+3% +$80K 1.03% 25
2020
Q4
$2.6M Buy
+15,418
New +$2.3M 0.97% 29

Other funds holding LLY